The inter-regional epidemiological study of childhood cancer analysed data on 234 children diagnosed with leukaemia or lymphoma and 468 controls matched for age and sex. A wide range of potential risk factors was examined, including prenatal exposure to x rays, maternal drug ingestion and smoking, child's medical history, and parental medical conditions and occupation. Calculations were completed for leukaemia or lymphoma and diagnostic subgroups, as defined by laboratory confirmed cell type. In utero exposure to narcotic analgesics was weakly associated with leukaemia or lymphoma but no other antenatal factors gave significant risks. New associations were identified for skin diseases in both parents and congenital abnormalities in the mothers of children with leukaemia. For past medical conditions in the child, viral disease occurring under 6 months of age increased the risk for acute lymphoblastic leukaemia. Fewer children in the leukaemia or lymphoma group had been immunised compared with the control groups. Case children diagnosed over the age of 9 years were more likely than controls to have had four or more previous episodes of illness. Overall, these results indicate that prenatal factors may be less important than postnatal or genetic influences in the development of leukaemia or lymphoma in children.
In the United Kingdom data have suggested a rise in the incidence of childhood leukaemia.' 2 The reasons for this increase remain obscure, in parallel with the failure of epidemiological studies to detect any major risk factors for childhood leukaemia or lymphoma. Advances in immunophenotyping of haematologic malignancies now permit the identification of distinct subtypes of diseases once thought to be single entities. Hence aetiological investigation of accurately classified disease phenotypes can be accomplished. As yet few epidemiological studies have incorporated this approach, particularly for childhood reticuloendothelial neoplasms.
(under 15 years) diagnosed with leukaemia or lymphoma were included and their parents interviewed with a standard questionnaire. Each case child was matched for age and sex with two healthy control children selected from admissions to hospital and general practitioner lists. Identical information was gathered from the parents of these control children as had been gathered from the parents of the children with leukaemia or lymphoma. Questions asked for details of the index antenatal period (illness, investigations, drug ingestion, complications, smoking, and alcohol consumption), medical history of the child, parents, and other family members, and parental occupation and smoking habits. Additional data were abstracted from medical notes. In particular, efforts were made to see relevant obstetric notes for every case and control mother interviewed. For both parents and child, diseases and conditions not related to pregnancy were coded according to the International Classification of Diseases,4 apart from gynaecological problems, which had unique IRESCC codes. Social class was assessed according to the father's occupation at the time of the child's birth. 5 An extensive range of risk factors was investigated for any possible association with childhood leukaemia or lymphoma. Preliminary tables for case control comparisons were produced using SPSS version X.6 Statistical analysis of cases versus pooled (hospital and general practitioner) controls was completed on a Hewlett Packard 41CV programmable calculator using the programs of Rothman and Boice.7 Relative risks were produced by the MantelHaenzsel method, with tests based on 95% confidence intervals and two tail p values. x2 and t tests were used when appropriate on certain variables.
Results
The distribution for sex and age at diagnosis of the 234 children with leukaemia or lymphoma who were interviewed is shown in Table 1 . They were not the complete set of incident cases from the three study regions because certain exclusions were made3 for pragmatic reasons. All 234 children with leukaemia or lymphoma had cytologically or histologically confirmed diagnoses. Of the 171 children with leukaemia, 148 were typed as acute lymphoblastic leukaemia, with common acute lymphoblastic leukaemia being confirmed by Professor M F Greaves in 78 patients. The 'other acute lymphoblastic leukaemia' group included diagnoses of uncertain cell origin, T cell, B cell, and null cell acute lymphoblastic leukaemia and 24 cases not submitted for cell typing, as detailed in Table 1 . Most of the other leukaemias were of myeloid For medically recorded ingestion of narcotic analgesics 15 case children exposed in utero were diagnosed, seven with common null cell acute lymphoblastic leukaemia, seven with acute lymphoblastic leukaemia, and one with myeloid leukaemia. Dextropropoxyphene hydrochloride (Distalgesic) was the commonest narcotic analgesic used and similar reasons were given by case and control mothers for its usage. Drugs adminisfered during labour were recorded only from medical notes. A significantly raised relative risk of 5.5 for barbiturates in the group with leukaemia or lymphoma was due to excessive numbers in the lymphoma subgroup (five cases (two Hodgkin's disease, three nonHodgkin's lymphoma), one general practitioner control, no hospital control; relative risk= 10-8, 95%
confidence intervals 1-8, 63-2; p<001).
In utero exposure to x rays was analysed using data from medical notes, counting direct fetal exposure from abdominal/pelvic x rays, and using pelvimetry. Ninety five per cent of pelvic films taken were in the third trimester for cases and controls. Reasons given for the prescription of giving x rays included suspicion of multiple pregnancy, fetal abnormality or presentation, 'checking dates'/ determining maturity, and a single instance of 'confirmation of engaged fetal head'. The relative risks for pelvic radiography were all greater than unity but not significant. Stratifying the 'pelvic' group by age at diagnosis gave seven cases, three general practitioner controls, and two hospital controls exposed in the group with leukaemia or lymphoma diagnosed under 2 years of age (relative risk=3-4, 95% confidence intervals 0 9, 12-9; p=007). The referent category of mothers had received no x rays of any type-for example, chest x rays. No risk for any other age reached significance.
Illnesses in parents. The medical history of the index child's mother and, where possible, father was recorded at interview. Attempts were made to confirm medically congenital abnormalities, cancers, and chronic diseases. The medical histories of the fathers and mothers of the index children did not differ significantly from those of the controls with regard to musculoskeletal and connective tissue disorders (ICD9 710-739), central nervous system disorders (ICD9 320-349), mental disorders (ICD9 290-319), or respiratory system diseases (ICD9 460-519). For skin diseases (ICD9 680-709), however, significant relative risks were present within the major diagnostic groups for both parents (Table 4 ). There was only one case of both parents of a case child having a skin condition. Medically recorded data showed a case excess for the leukaemias (fathers: eight cases, three general practitioner Table 4 . Much of the excess was due to ICD9 757.9-mainly nonspecific birthmarks. Case control comparisons for all diagnostic groups gave no increased risk for the following gynaecological conditions occurring either before or after the index pregnancy: fibroids, cysts and polyps of the genital tract, infertility, and menorrhagia.
Child's medical history. Details of congenital anomalies, chronic disease, and childhood illnesses were obtained for the index child, but medical confirmation was sought routinely only for major congenital abnormalities and chronic diseases. Case control comparisons were made for respiratory system diseases (ICD9 460-5 19), central nervous system disorders (ICD9 32()-349), and skin diseases (ICD9 680-709), but large numbers of reported conditions were of a non-specific nature. No case control differences were evident for these conditions. Viral diseases (ICD9 045-079, 408), comprising chickenpox, rubella, measles, .mumps, viral meningitis, and viral influenza, were recorded at interview if the episodes occurred when the child was under 6 months of age. In the group with leukaemia or lymphoma a significantly increased number of case children were noted to have had viral illnesses (Table 5 ). This was accounted for particularly by the common null cell acute lymphoblastic leukaemia and lymphoma subgroups (Table 6) . No significant differences were present for respiratory system disorders or skin diseases diagnosed under 6 months of age. Children with viral disease in the six months before diagnosis were excluded from analysis. Reports of early viral diseases were proportionately distributed between the three regions that contributed data.
Analysis of the total number of episodes of illness for each child revealed that case children had an increased frequency of diseases compared with controls. Comparing a history of three or less instances with four or more, risks approached and reached significance for reported and medically recorded data, respectively, in the group with leukaemia or lymphoma ( Table 5 ). The children with leukaemia accounted for the reported excess, with the children with lymphoma showing a significant risk for medically recorded illness due to three cases of non-Hodgkin's lymphoma and no controls. On stratification by age at diagnosis (under 2 years, 2-8 years, and 9-14 years) a significant excess was shown only in the 9-14 age group. showing an increased risk (relative risk 3.4) for leukaemia or lymphoma diagnosed under 2 years of age. Reduction of significance in the present analysis compared with previous datall can be explained, firstly, by differences in the assignment of controls. In the original letter controls with histiocytosis X were not excluded from the stratified analysis. Secondly, the total number of cases with leukaemia or lymphoma was reduced from 245 to 234 by removal of the nine cases with histiocytosis X (six diagnosed under 2 years) and two instances where diagnostic review resulted in recategorisation from the group with leukaemia or lymphoma. The results expressed in this x ray analysis follow the stratified format adopted throughout the paper, and although the relative risk for x rays is still high for the group with leukaemia or lymphoma, the smaller numbers in the cells fail to achieve significance.
Any drug ingested during pregnancy has the potential to cross the placenta, presenting a hazard to the developing fetus. According to medical records, barbiturates were administered during labour to more mothers of children with lymphoma than to the mothers of the matched controls. This association was lost when barbiturates at any time during the index pregnancy were examined, making them unlikely transplacental carcinogens.
This study gathered detailed information on the medical history of both-parents. Analysis of ICD9 coded groups showed no case excesses in any category except for mothers and fathers with skin diseases, where the association was most prominent for acute lymphoblastic leukaemia. No particular condition was more prevalent for either parent and it is of interest that maternal and paternal links existed. These findings are unique and require corroboration from other independent studies. A Yorkshire case control study of adult leukaemia and lymphoma found a case excess of skin disease in the patients themselves.'6 We are unable to hypothesise a causal explanation, although skin diseases may well be markers of some other associated inherited factor, such as a malfunctioning immune system. The frequency of congenital anomalies in the parents of children with leukaemia or lymphoma has not been previously reported and the significant excess of mothers, mainly in the group with leukaemia, is of interest but as yet inexplicable.
A striking finding from our data on the leukaemia or lymphoma group was the significant relative risk for contracting a viral disease under the age of 6 months. The development of leukaemia or lymphoma has long been linked to malfunctioning immunity, and the maturing neonatal immune system requires time to develop active immunity in response to antigenic stimulation, making early exposure to disease particularly relevant. Based on this idea we recorded all instances of infections under the age of 6 months. No case excess was found for any disease occurring after 6 months and the significance of viral exposure at a younger age was limited to the pooled leukaemia or lymphoma group. The latent period between viral exposure and malignancy ranged from 2*5 to 5-5 years for cases of acute lymphoblastic leukaemia; numbers in other groups were small, ranging from 4*5 to 14-5 years.
For acute lymphoblastic leukaemia, the minimum gap of 2-5 years makes it unlikely that the viral disease was expressed due to intrinsic immunosuppression in the preclinical phase of malignancy, which Stewart estimated as one year. 17 The rarity of both leukaemia or lymphoma in childhood and viral disease under 6 months means that our risk estimates are based on small numbers. In contrast, one study has shown that children with leukaemia have fewer infections in the first year of life. 18 Further conflict is apparent from our own data, where an excess of case children were not immunised. Small numbers make this apparent protective effect of immunisation an unreliable observation, although another recent and larger study had similar findings.'9 The role the immune system plays in haematopoietic malignancies is unclear, and our association with early viral disease may be independent of immune regulation and effect malignant transformation through another route.
The association between childhood leukaemia or lymphoma and increased episodes of previous illness could be explained by over reporting by mothers of cases or under reporting by control mothers. This, however, seems unlikely because the case control differences are present for both interview reports and medically recorded conditions. Also the fact that the effect was strongest in the 9-14 age group is evidence against over reporting by case mothers. It was impossible in this study to assign the excess to one particular disease group or to determine whether any conditions were related to a susceptible period before diagnosis.
Parental One of the initial troubles with ultrasound examinations is the difficulty in endeavouring to relate the images produced to anatomy and pathology. Most find a period of apprenticeship the easiest way to overcome this problem. The applications of ultrasound to that eminently suitable subject, the young child, continue to increase.
This timely publication allows one to share the experience of pioneers of sonographic examination of infants' hip joints. The book is essentially a profusely illustrated atlas of the normal and abnormal appearances of the hip joint, with clearly annotated anatomical details. Introductory chapters provide photographic illustration of the correct positioning and scanning techniques, with sections on instrumentation, adjustment, and documentation. The first half of the book is essentially descriptive, in which the spectrum of acetabular dysplasia and hip dislocation is well presented. The second half of the book is mostly concerned with the quantative evaluation of hip sonograms, with associated angular measurements, which Dr Graf in particular has developed.
Not all ultrasonographers would feel inclined to use this technique or abide by the classifications, but the qualitative value of the illustrations in these sections remains useful and informative, and as a practical atlas the work can be commended. TIhrotughout this piapcr for tlhe tc-rmi commiiilon null ccll acutc lvmphohliastic lcukacnmia plesc r-cad common acutc lymphohlastic lcukaemia'. This crror occurs only in the contcxt of this papcr.
